Visual Acuity
Phase 2 trial of EYP-1901 in wet AMD meets all endpoints
The phase 2 DAVIO 2 trial of EYP-1901 met all primary and secondary endpoints in patients with wet age-related macular degeneration, EyePoint Pharmaceuticals announced in a press release.
VIDEO: Study shows optogenetic therapy safe, improves visual function in Stargardt disease
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Sam Barone, MD, of Nanoscope Therapeutics discusses efficacy and safety data for the company’s MCO-010 optogenetic therapy.
VIDEO: Analysis finds similar BCVA, superior CST for faricimab vs. aflibercept in DME
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Marco A. Zarbin, MD, PhD, FACS, discusses a post hoc analysis of faricimab vs. aflibercept in patients with DME and visual acuity of 20/50 or worse.
VIDEO: OmniVu IOL system shows stability, good refractive predictability
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, discusses the 12-month results of the first-in-human clinical trial of the OmniVu IOL system from Atia Vision.
VIDEO: Cell therapy for corneal endothelial disease shows sustained improvements in BCVA
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Eris Jordan, OD, vice president of global clinical and medical affairs at Aurion Biotech, discusses the company’s novel cell therapy for corneal endothelial disease.
Comprehensive tests needed to determine driving safety in patients with glaucoma
SAN FRANCISCO — Glaucoma is associated with an increased risk for motor vehicle collisions, but more advanced methods of testing are needed to determine the level of driving safety in individual patients, according to a speaker here.
VIDEO: APX3330 shows promise in slowing diabetic retinopathy progression
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, George Magrath, MD, MBA, MS, CEO of Ocuphire Pharma, provides an update on APX3330 for the treatment of diabetic retinopathy.
VIDEO: Post hoc analyses begin to show less vision loss with GA treatments
NEW YORK — In this Healio Video Perspective from OSN New York Retina, Carl D. Regillo, MD, discusses his presentation on the latest data from the phase 3 studies of pegcetacoplan and avacincaptad pegol for treating geographic atrophy.
Study evaluates potential of GPT-4 in prioritizing medical waiting lists
A study showed moderate agreement between GPT-4 and retina specialists in assessing need for treatment and urgency of treatment in patients with diabetic retinopathy, according to a poster presentation at Real World Ophthalmology.
VIDEO: Post hoc analysis shows impact of better baseline vision on DME outcomes
In this Healio Video Perspective, Dilraj Grewal, MD, discusses an analysis of the VISTA and VIVID studies exploring the impact of baseline vision on visual outcomes and vision-related quality of life function in diabetic macular edema.